Heart disease is a major cause of mortality worldwide, so identifying mechanisms that regulate cardiac physiology is a crucial step toward its treatment and prevention. Both vertebrate and invertebrate models contribute to our understanding of cardiovascular physiology and the related disease processes affecting humans. The *Drosophila* heart comprises contractile cardiomyocytes and neighboring pericardial nephrocytes that clear circulating colloids, macromolecules, and immune peptides from the hemolymph (blood).^[@R1]--[@R3]^ This organ system has proven to be a tractable model that permits genetic screens to identify novel pathways relevant to human cardiac performance.^[@R4]^ In addition, functional studies have contributed to our understanding of how alterations in structural proteins, including adhesion proteins such as fermitins/kindlins^[@R5]^ and contractile proteins, such as myosin and troponin-T, translate to cardiomyopathy.^[@R6]^ In addition, *Drosophila* has facilitated the elucidation of genetic pathways regulating cardiac aging^[@R7],[@R8]^ and diet-induced cardiac and kidney podocyte dysfunction.^[@R9]--[@R11]^

**Editorial see p 104**

**Clinical Perspective on p [129](#s1){ref-type="sec"}**

There is evidence that cardiac phenotypes develop in the *Drosophila* model as a result of nephrocyte dysfunction; however, the mechanisms are not well characterized.^[@R12]--[@R15]^ It has also been reported that these cardiac phenotypes may depend on developmental changes to the nephrocyte--cardiomyocyte niche rather than a contribution by nephrocytes to cardiac homeostasis in adulthood.^[@R16]^ Characterizing the noncell autonomous regulation of heart function in flies is important because it may provide insights into molecules that regulate human cardiac physiology.

The *Drosophila* ortholog of the mammalian transcription factor *Klf15* (also known as Kidney Kruppel-like factor) has recently been identified as a nephrocyte-restricted gene critical for the cells' differentiation and function.^[@R17]^ Pericardial nephrocytes in flies homozygous for a *dKlf15* loss of function allele develop normally during embryonic cardiogenesis but then fail to differentiate during larval development and undergo attrition before pupation, hence adult flies have no pericardial nephrocytes. This enables the nephrocytes' impact on the circulating proteome in adults to be analyzed and for nephrocyte-dependent cardiomyocyte control mechanisms to be identified.

In this work, we took advantage of the nephrocyte--cardiomyocyte system in *Drosophila* to identify circulating cardiomodulatory factors of potential relevance to humans. Proteomics was used to establish the composition of the circulating proteome in flies with and without nephrocytes. It was found that either the loss of nephrocytes or their function during development led to cardiomyopathy, and contrary to previous reports, loss of nephrocyte function in adulthood also led to cardiomyopathy. Analysis of the hemolymph proteome established that nephrocytes had a broad impact on the circulating secretome. By coupling the proteomics data with genetic experiments, we showed that nephrocytes regulated circulating levels of the matricellular protein secreted protein acidic and rich in cysteine (SPARC) and prevent SPARC-dependent cardiomyopathy. SPARC plays multiple roles in mammals. SPARC levels increase in metabolic syndrome and aging, and it is well documented as contributing to pathological tissue fibrosis; however, reduced *SPARC* expression can lead to heart rupture in pressure overload models.^[@R18]^ The current findings suggest that SPARC's role in the mammalian heart may be evolutionarily conserved and that its modulation may ameliorate cardiac dysfunction. The work also highlights the importance of *Drosophila* for the identification and study of cardiomodulatory signals of relevance to human cardiac physiology.

Materials and Methods
=====================

Strains Used in This Study
--------------------------

The *w*^*1118*^ (used as wild-type strain in this study), *dKlf15*^*NN*^ (*CG2932*, FBgn0025679; previously known as *Bteb2*^*f06447*^ was described in the study by Ivy et al^[@R17]^), *Dorothy-Gal4* (*dot-Gal4*, originally described in the study by Kimbrell et al^[@R19]^), *UAS-mCherry* (TRiP control line), *dSparc*^*MI00329*^ (with an MiMIC insertion in the 5-prime region of the *dSparc* locus; as described in the study by Venken et al^[@R20]^), and *Tub-Gal80*^*ts*^ lines were all from the Bloomington Stock Center (Bloomington, IL). The *HandC-Gal4* (*Hand-Gal4*) line was described in the study by Sellin et al^[@R21]^). The 2 RNAi lines for knocking-down *dKlf15* were from the Vienna Drosophila RNAi stock Center (with a targeting hairpin inserted into the second chromosome, VDRC) and Bloomington (*Klf15*^*JF02420*^, a Harvard TRiP line with a *dKlf15* targeting hairpin inserted into the third chromosome). All genetic combinations were generated by standard crosses. Generation of TARGET flies (*Hand-Gal4*; *Tub-Gal80*^*ts*^) was achieved by standard crosses.^[@R22]^

Husbandry and Propagation of Flies
----------------------------------

Flies were propagated routinely on a cornmeal-molasses diet at 25°C under a 12:12 hour light:dark schedule. For TARGET experiments, flies were reared at 18°C and then transferred to 29°C within 1 to 5 days of eclosing. Flies remained at 29°C for 1 to 2 weeks. After analysis of heart function, flies were transferred to 25°C for 24 hours. To reduce the effect of genetic background, the *dKlf15*^*NN*^ mutant was backcrossed onto the *w*^*1118*^ for \>20 generations.

Quantitative PCR
----------------

See Methods section in the Data Supplement.

Imaging the Adult Heart
-----------------------

See Methods section for more detailed description of the method in the Data Supplement. Unless stated otherwise, 2- to 3-week-old adult female flies were anaesthetized with Flynap (Carolina Biological Supply Company, Burlington, NC), dissected and hearts stained as described previously.^[@R5],[@R23]^

Analysis of Adult Heart Function
--------------------------------

Two- to three-week-old adult flies were anesthetized with Flynap (Carolina Biological Supply Company), and the beating adult heart in semi-intact preparations was visualized with an Ionoptix Myocam S high frame rate video camera (Ionoptix Ltd, Dublin, Ireland) attached to a Zeiss AxioLab A1 with a water-dipping 10× objective. Approximately 15 s of video footage was collected using Micro-Manager open source microscopy software,^[@R24]^ with a frame rate capture of between 120 and 150 frames per second. Videos were converted to audio video interleave files using ImageJ and analyzed using semiautomated optical heart analysis software,^[@R25]^ [www.sohasoftware.com](www.sohasoftware.com); as previously described.^[@R5]^ Quantified data are presented as the mean (±SEM) of at least 20 different flies per genotype.

Epifluorescence Microscopy of Adult Fly Tissues
-----------------------------------------------

See Methods section in the Data Supplement.

Collection of Hemolymph From Adult Flies
----------------------------------------

One-week-old adult female flies were rendered immobile at 4°C for 5 minutes. To remove contaminating food and feces flies were placed into a 1.5-mL centrifuge tube and 500-μL of 50% ice cold ethanol in water and the tube upturned several times. This step was repeated a further 2×, first with 50% ethanol and then with 50-mmol/L ammonium bicarbonate. Flies were then tipped onto an upturned 30-mm petri dish containing ice. The dorsal cuticle of the thorax of at least 100 flies was pricked with a 25G needle and then flies were collected into a centrifuge tube containing a 0.2-μm filter insert and 1 mL of 50-mmol/L ammonium bicarbonate. Flies were centrifuged at 4°C for 10 s at 2000 rpm (g value, 448g). The filtrate was removed and replaced into the upper filter cassette and centrifuged again. This step was repeated once more. The protein concentration of the filtrate was quantified by the Bradford assay using 50-mmol/L ammonium bicarbonate as a blank. Samples from flies that had not been pricked contained no protein. Samples contained 100 to 150 μg of total protein and were frozen at −20°C; volumes were adjusted with 50-mmol/L ammonium bicarbonate to normalize the total protein content between the samples. The mean spectral count of 3 independent biological replicates from the reference (*w*^*1118*^) and *dKlf15*^*NN*^ mutant genotypes was used to infer protein abundance.

Proteomic and Bioinformatics Analysis of Hemolymph Proteome
-----------------------------------------------------------

Hemolymph samples were lyophilized and resuspended in 200 μL with 50-mmol/L ammonium bicarbonate. Protein reduction was done by adding 4 μL of Tris(2-carboxyethyl)phosphine to 200 μL of samples at 60°C for 30 minutes. Iodoacetamide was added (to 20 mmol/L), and proteins were alkylated at 30 minutes at room temperature in the dark. Mass spectrometry grade trypsin (Promega) was added (1:20 ratio) for overnight digestion at 37°C on thermomixer set on 700 rpm. After digestion, formic acid was added to the peptide solution (to 2%), followed by desalting by Microtrap (Michrom-Bruker) and then on-line analysis of peptides by high-resolution, high-accuracy LC--MS/MS, consisting of a Michrom HPLC, an Agilent Zorbax C18 peptide trap, a 15-cm Michrom Magic C18 column, a low-flow ADVANCED Michrom MS source, and an LTQ-Orbitrap XL (Thermo Fisher Scientific). A 120-minute gradient of 10% to 30%B (0.1% formic acid and 100% acetonitrile) was used to separate the peptides. The total LC time was 140 minutes. The LTQ-Orbitrap XL was set to scan precursors in the Orbitrap followed by data-dependent MS/MS of the top 10 precursors. The LC--MS/MS raw data were submitted to Sorcerer Enterprise v.3.5 release (Sage-N Research Inc) with SEQUEST algorithm as the search program for peptide/protein identification. SEQUEST was set up to search the target-decoy Swiss-Prot *Drosophila melanogaster* fasta protein database indexed with trypsin for enzyme with the allowance of ≤2 missed cleavages, Semi Tryptic search, and precursor mass tolerance of 50 ppm. The search results were viewed, sorted, filtered, and statically analyzed by using comprehensive proteomics data analysis software, Peptide/Protein prophet v.4.6.1 (Institute for Systems Biology, Seattle). The minimum transproteomic pipeline protein probability score was set to 0.8 to 0.90, to assure low error (much less than false discovery rate 2%) with reasonably good sensitivity. The differential spectral count analysis was done by QTools, an open source in-house developed tool for automated differential peptide/protein spectral count analysis and Gene Ontology.^[@R26]^ SignalP 4.1 was used to identify proteins having a signal peptide sequence in their N terminus; default settings with a D cutoff of 0.45 were used.^[@R27]^

Statistics
==========

When \>2 genotypes or treatments were used in an experiment, 1-way ANOVA was used to test the hypothesis that genotype may have affected heart function, and post hoc test (Tukey honest significant difference) was used to establish *P* values between control and the different genotypes. An unpaired 2-tailed student's *t* test was used to compare 2 means. GeneProf^[@R28]^ was used to calculate the probability that hemolymph samples may be enriched with proteins predicted to have an N-terminal signal peptide versus a background data set (the proportion of all known Drosophila genes predicted to encode for an N-terminal signal peptide).

Results
=======

Genetic Ablation of Nephrocytes Using *dKlf15* Loss of Function
---------------------------------------------------------------

It has recently been demonstrated that *dKlf15* is a nephrocyte-restricted transcription factor critical for the viability and differentiation of *Drosophila's* 2 nephrocyte populations, the garland cells and pericardial nephrocytes.^[@R17]^ In flies homozygous for a *dKlf15* loss of function allele (*dKlf15*^*NN*^), the nephrocyte populations undergo attrition during late embryogenesis (garland cells, compare Figure [1](#F1){ref-type="fig"}B′ and 1B″ and the L3 stage of larval development, so that adults are completely devoid of nephrocytes (compare Figure [1](#F1){ref-type="fig"}A′ and 1A″).

![Loss of pericardial nephrocytes and garland cells in *dKlf15*^*NN*^ mutants. **A**, Adult control (*w*^*1118*^; **A**′) and *dKlf15*^*NN*^ mutant flies (**A**″) were dissected and the heart fixed and stained with phalloidin to visualize the heart's actin cytoskeleton and antibodies to the pericardial nephrocyte marker Amnionless (*CG11592*). All pericardial nephrocytes fail to differentiate in the mutants, undergoing attrition during late larval development so that by adulthood there are none. **B**, Third instar larvae were dissected and the garland cells visualized after staining with Hoechst. In control flies (*w*^*1118*^; **B**′) garland cells (GCs) are binucleate and situated at the interface between the proventriculus (PV) and esophagus (OE). In contrast, the garland cells fail to develop normally and are lost in the *dKlf15*^*NN*^ mutants (**B**″). Scale bar, 100 μm.](hcg-9-119-g001){#F1}

Loss of Nephrocyte *dKlf15* Expression Leads to Cardiomyopathy
--------------------------------------------------------------

It is increasingly clear that *Drosophila* heart function is modulated by noncell autonomous mechanisms controlled by the neighboring pericardial nephrocytes.^[@R14],[@R15]^ To confirm that nephrocytes modulate cardiac function in the *Drosophila* model, adult hearts in wild-type and *dKlf15*^*NN*^ mutants were monitored by videomicroscopy. Homozygous *dKlf15*^*NN*^ mutant females (and hemizygous *dKlf15*^*NN*^ mutant males) had significantly longer heart periods (the time between the initiation of successive cardiac contractions) compared with controls, primarily because of a significant lengthening of the diastolic interval (Figure [2](#F2){ref-type="fig"}A and [2](#F2){ref-type="fig"}B for data from males see below). The mutants also had a modest increase in the arrhythmicity index (Figure [2](#F2){ref-type="fig"}B), a measure of the heart's beat-to-beat variability. In addition, end-diastolic and end-systolic diameters (EDD and ESD) were greater in mutants than in controls; however, this was not associated with a change in fractional shortening (the ratio of EDD to ESD---the relative distance that the heart wall travels during a contraction). To establish if the heart phenotype was because of the specific loss of nephrocyte *dKlf15* expression, *dKlf15* was silenced specifically in nephrocytes using *dorothy-Gal4*. Knockdown of *dKlf15* in nephrocytes led to a heart phenotype that was almost identical to that of the *dKlf15*^*NN*^ mutants; however, the arrhythmicity index, although trending toward being increased, was not statistically different from that of the controls (Figure [2](#F2){ref-type="fig"}B).

![Loss of nephrocytes leads to cardiomyopathy. A, M-mode records of adult hearts. Regular contractions can be seen in wild-type (*dKlf15*^+/+^), *dKlf15*^+/*NN*^ heterozygote, and *dot-Gal4* outcrossed once to the *w*^*1118*^ control line (*dot-Gal4 x w*^*1118*^); whereas flies homozygous for the *dKlf15*^*NN*^ allele, or in which *dKlf15* has been silenced in nephrocytes (*dot-Gal4; UAS-dKlf15*^*RNAi*^), there is an abnormally long diastolic interval and periods of arrhythmia. **B**, Adult heart function. EDD indicates end-diastolic diameter; ESD, end-systolic diameter; and ns, not statistically different from *dKlf15*^+/+^ or *dot \> w*^*1118*^ control; \**P*\<0.01 compared with *dKlf15*^+/+^; †*P*\<0.01 compared with *dot \>w*^*1118*^); n=41 to 45 flies per genotype.](hcg-9-119-g002){#F2}

Nephrocytes Mediate Normal Cardiac Function in Adults
-----------------------------------------------------

There is a doubt as to whether normal heart function in adult flies is dependent or not on sustained interactions between cardiomyocytes and nephrocytes. Sustained *dKlf15* expression is required for adult nephrocyte function,^[@R17]^ so to establish if nephrocytes were required for normal cardiac function in adult flies, the TARGET system^[@R22]^ was used to silence *dKlf15* in the nephrocytes of adult flies (Figure [3](#F3){ref-type="fig"}). Using this system, it was possible to allow functional nephrocytes to develop normally and then silence *dKlf15* in adults to cause nephrocyte dysfunction. Accordingly, nephrocytes dedifferentiated (showed reduced Amnionless protein expression) and lost their ability to accumulate dextran. In association with this, the flies developed a cardiomyopathy, which recapitulated that seen in the *dKlf15*^*NN*^ mutants as well as *dorothy-Gal4*--driven *dKlf15* silencing experiments (Figure [3](#F3){ref-type="fig"}B).

![Conditional loss of nephrocyte function in adults leads to cardiomyopathy. *dKlf15* was conditionally silenced in the adult fly heart using the temperature-sensitive TARGET system driven by *Hand-Gal4*. Gene silencing is prevented at 18°C but permitted at higher temperatures (29°C). Flies were reared at 18°C until they eclosed and then maintained at this temperature to prevent gene silencing or moved to the higher temperature to allow *dKlf15* silencing. The *Hand-TARGET* parent line crossed to *w*^*1118*^ line or *UAS-mCherry* was used as controls. **A**, The endocytic function (ability to take-up fluorescently labeled dextran) was used to assess nephrocyte function. At the nonpermissive temperature, nephrocytes in all genotypes were able to accumulate dextran. When shifted to the permissive temperature the nephrocytes in control flies were still able to accumulate dextran, but flies in which *dKlf15* had been silenced could not. **B**, Quantification of heart function in adult flies reared at 18°C until eclosion and then transferred to 29°C for 2 weeks. The beating heart was imaged in semi-intact preparations using high frame rate video microscopy. n=20 for each genotype. EDD indicates end-diastolic interval; ESD, end-systolic diameter; and ns, not significantly different from Target or *w*^*1118*^; \* and †*P*\<0.01 compared with Target, *w*^*1118*^ or Target; UAS mCherry controls, respectively.](hcg-9-119-g003){#F3}

Reduction of Nephrocyte *Amnionless* Expression Is Associated With Cardiomyopathy
---------------------------------------------------------------------------------

*Amnionless* is crucial for nephrocyte function,^[@R29]^ so it was hypothesized that loss of *Amnionless* may be sufficient to cause cardiomyopathy. Silencing *Amnionless* in nephrocytes did not cause nephrocyte death but did impair nephrocyte endocytic function (Figure [4](#F4){ref-type="fig"}A and 4B). Importantly, silencing *Amnionless* affected cardiac function by increasing the heart period because of a lengthening of the diastolic interval (Figure [4](#F4){ref-type="fig"}C), similar to the phenotype in *dKlf15* loss-of-function experiments.

![Loss of Amnionless function in nephrocytes leads to cardiomyopathy. **A**, *Amnionless* was silenced in nephrocytes using *dot-Gal4*. As a negative control, the parent driver line was outcrossed once to the *w*^*1118*^ line (*dot-Gal4 x w*^*1118*^) and offspring analyzed. Micrographs show adult hearts stained with anti-Amnionless antibodies (green) and phalloidin (red). Amnionless protein was localized to nephrocytes in controls (**A**′), whereas silencing led to reduction in its detection but not the loss of pericardial nephrocytes (**A**″; arrow indicates a pericardial nephrocyte); HT indicates heart tube. **B**, Semi-intact heart preparations were incubated with fluorescently tagged 10-kDa dextran (green) and wheat germ agglutinin (red) for 30 minutes, washed and imaged. Arrows indicate nephrocytes. Dextran accumulated in controls (**B**′) but not in *Amnionless*-silenced nephrocytes (**B**″). WGA indicates wheat germ agglutinin. **C**, Quantification of heart function in flies with *Amnionless* silenced nephrocytes. Hearts were analyzed by high frame rate video microscopy of semi-intact adult heart preparations. EDD indicates end-diastolic interval; ESD, end-systolic diameter; EDD/ESD, fractional shortening of the heart contraction; and ns, not statistically different from control genotype (*dot-Gal4* x *w*^*1118*^); \**P*\<0.01, †\*\<0.05; n=18 to 20 per genotype.](hcg-9-119-g004){#F4}

Disruption of the Hemolymph Proteome in *dKlf15* Loss of Function Flies
-----------------------------------------------------------------------

Given that disruption of nephrocyte endocytosis was associated with the development of cardiomyopathy, it was hypothesized that nephrocytes may regulate levels of circulating, cardiomodulatory signals. We therefore examined the hemolymph proteome of control and *dKlf15*^*NN*^ mutants using a method similar to that used by others to identify \>700 larval hemolymph peptides.^[@R30]^ Signals corresponding to 495 different proteins were identified. Of these, 209 were identified in the hemolymph of both genotypes, 192 were identified only in the control strain, and 94 were found only in *dKlf15*^*NN*^ mutants (Figure [5](#F5){ref-type="fig"}A).

![Proteomic analysis of adult *Drosophila* hemolymph. Hemolymph was collected from adult flies and the proteome analyzed. **A**, Number of different proteins identified in the hemolymph of adult control (*w*^*1118*^) and mutant *dKlf15*^*NN*^ flies. **B**, The number of proteins predicted to have a signal peptide by SignalP 4.1. **C**, Heat map showing a truncated list of proteins identified only in the hemolymph of *dKlf15*^*NN*^ mutants. Proteins are rank ordered according to spectral count; each row represents 3 independent samples from each genotype (Table I in the Data Supplement). **D**, Coverage of secreted protein acidic and rich in cysteine (SPARC) protein sequence by detected peptides (yellow corresponds to regions detected in proteomics).](hcg-9-119-g005){#F5}

Proteins were allocated to 5 nonoverlapping groups (Table I in the Data Supplement); (group 1) unique to *dKlf15*^*NN*^ mutants; (group 2) increased at least 2-fold in *dKlf15*^*NN*^ mutants; (group 3) present in both genotypes and within 0.8- to 2-fold different in mutants relative to controls; (group 4) reduced by \>0.8-fold in the mutants relative to controls; and (group 5) unique to controls.

It was predicted that ablation of the nephrocytes would lead to the accumulation of secreted proteins in circulation. To address this possibility, the SignalP 4.1 informatics tool was used to identify proteins predicted to have a signal peptide in their N-terminal region, a sequence associated with transport to the extracellular space.^[@R27]^ Of the 448 proteins identified in the circulation of the reference strain, 39% were predicted to contain an N-terminal signal peptide (Figure [5](#F5){ref-type="fig"}B). In contrast, the hemolymph of the nephrocyte-free mutants was enriched for proteins predicted to contain a signal peptide (81%). In comparison with the total number of *Drosophila* genes predicted to encode signal peptides (3173 of 17 559 known genes, 18%), it was established that hemolymph proteome is enriched for proteins with signal peptides (*P*=3.827e-30), and that in the absence of nephrocytes, there is further enrichment for proteins with signal peptides compared with wild-type hemolymph (*P*=7.408e-35). These data are consistent with nephrocytes having a broad impact on the circulating proteome and suggest that loss of nephrocyte function causes the accumulation in the circulation of a large subset of secreted proteins.

Of the proteins found only in the *dKlf15*^*NN*^ mutants (group 1), the most abundant signals were for the matricellular protein BM-40-SPARC (an ortholog of mammalian SPARC (Figures [5](#F5){ref-type="fig"}C, 5D, and 6A)^[@R31]^) and the cell adhesion protein DE-cadherin (encoded by shotgun, *shg*). Analysis of the SPARC peptide peak areas confirmed the absence of SPARC in the wild-type hemolymph (Figure I in the Data Supplement). Proteins significantly upregulated in the hemolymph of *dKlf15*^*NN*^ mutants compared with wild-type flies (group 2; Figure [6](#F6){ref-type="fig"}B) included 3 genes with unknown functions (CG18067, CG15293, and CG14961; upregulated 27-, 9-, and 8.5-fold, respectively; *P*\<0.05) as well as several proteins involved in immunity and clotting (gelsolin, immune-induced peptides 10 and 23 and the defence protein l(2)34F; *P*\<0.05). The immune modulatory serpin necrotic^[@R1]^ trended toward a 3-fold accumulation in the mutants' hemolymph.

![Mean spectral counts of hemolymph proteins. **A**, Counts for 2 most abundant proteins found only in the *dKlf15*^*NN*^ mutants hemolymph. **B**, Proteins showing an increase in the mutant's hemolymph. **C**, The most abundant proteins in the hemolymph of wild-type and *dKlf15*^*NN*^ mutants. **D**, Proteins significantly reduced in the hemolymph of the *dKlf15*^*NN*^ mutants. **E**, Proteins showing the largest, statistically significant, decrease in the mutant's hemolymph; n=3 independent hemolymph samples from ≈100 flies of each genotype; \**P*\<0.05, ns indicates no significant difference. SPARC indicates secreted protein acidic and rich in cysteine.](hcg-9-119-g006){#F6}

Of the proteins common to both genotypes and at similar levels (group 3, Figure [6](#F6){ref-type="fig"}C), the largest spectral counts corresponded to the lipophorin, retinoid-binding and fatty acid--binding glycoprotein (*Rfabg*; spectral count of 2260±785 and 2097±570 for wild-type and mutant hemolymph; *P*=0.88) and the yolk proteins/vitellogenins (VIT 1, 2, and 3). Proteins with large spectral counts in the wild-types that were significantly downregulated in the mutants hemolymph (group 4; Figure [6](#F6){ref-type="fig"}D) included several intracellular cytoskeletal and metabolic proteins (aldolase, enolase, and subunits of glyceraldehyde phosphate dehydrogenase enzyme). Finally, proteins unique to wild-type hemolymph (group 5, Figure [6](#F6){ref-type="fig"}E) included peroxiredoxin 5 (*Prdx5*; spectral count of 16±4 in wild-type and 2±1 in the mutant, *P*\<0.05), iron regulatory protein 1B (*Irp1B*; spectral count of 22±6 in wild-type and 4±1 in mutant, *P*\<0.05), and vacuolar H+ ATPase 68-kDa subunit 2A (*Vha68-2*; spectral count of 13±2 in wild-type, undetected in the mutant, *P*\<0.05).

A *dSparc*^*MI00329*^ Mutation Corrects the Cardiomyopathy in *dKlf15*^*NN*^ Mutants
------------------------------------------------------------------------------------

Of the proteins unique to the *dKlf15*^*NN*^ mutants' hemolymph, SPARC was notable because of its role in collagen deposition and several growth factor signaling pathways thought to affect cardiac function.^[@R32],[@R33]^ We therefore tested whether *SPARC* contributed to the observed cardiomyopathy. We obtained a recessive lethal *Drosophila SPARC* allele (*dSparc*^*MI00329*^) caused by the insertion of a 7.3-kb MiMIC transposon in the 5-prime untranscribed region of the *dSparc* open reading frame.^[@R20]^ Homozygous adults do not develop, however, *dSparc*^*MI00329*^ heterozygotes are viable, fertile, and develop to adulthood, albeit with *dSparc* gene expression reduced by 60% (Figure [7](#F7){ref-type="fig"}A). Homozygous *dKlf15*^*NN*^ mutant females were crossed with males carrying the *dSparc*^*MI00329*^ allele, and then the heart function of male progeny (ie, those hemizygous for *dKlf15*^*NN*^ and heterozygous for the *dSparc*^*MI00329*^ allele) was analyzed. It was found that the *dKlf15*^*NN*^ mutant males had no nephrocytes and exhibited cardiomyopathy characterized by long diastolic intervals, similar to the phenotype of homozygous *dKlf15*^*NN*^ mutant females (cf Figures [2](#F2){ref-type="fig"} and [6](#F6){ref-type="fig"}). However, heart function parameters in *dSparc*^*MI00329*^ heterozygotes (*w*^*1118*^; *dSparc*^*M100329*^) were not different from those of control *w*^*1118*^ flies, and specifically there was no increase in heart period/diastolic intervals as observed for hearts from hemizyogous *dKlf15*^*NN*^ mutants (Figure [7](#F7){ref-type="fig"}B). In contrast, when *Sparc* was silenced in wild-type cardiomyocytes, there was a significant impact on heart function (Figure II in the Data Supplement). Importantly, reducing *dSparc* expression rescued the abnormal heart phenotype in hemizygous *dKlf15*^*NN*^ mutants ((*dKlf15*^*NN*^; *dSparc*^*M100329+/−*^; Figure [7](#F7){ref-type="fig"}B), despite these flies having no nephrocytes. The findings demonstrate that heterozygosity for *SPARC* leading to reduced gene expression has no direct impact on cardiac function in the wild-type flies, whereas it ameliorates the cardiomyopathy caused by *Klf15*-induced loss of nephrocytes.

![Secreted protein acidic and rich in cysteine (SPARC) mediates cardiomyopathy in *dKlf15*^*NN*^ mutants. The heart function of 2-week-old male flies of different genotypes was analyzed in semi-intact fly preparations using high frame rate videomicroscopy. Quantified data for several parameters are presented. EDD indicates end-diastolic diameter; and ESD, end-systolic diameter. \*Different from *w*^*1118*^ (*P*\<0.01); †Not different from *w*^*1118*^ (*P*\>0.05); ‡Different from *dKlf15*^*NN*^ (*P*\<0.01); §Not different from *w*^*1118*^; *dSparc*^*MI00329*^ (*P*\>0.05); ¶Not different from *dKlf15*^*NN*^ (*P*\>0.05); ns, not different from *w*^*1118*^ (*P*\>0.05); n=40 to 69 flies per genotype.](hcg-9-119-g007){#F7}

Discussion
==========

The *Drosophila* heart model represents a highly tractable genetic system with which to study mammalian cardiac physiology. Although at an anatomic level the links between fly nephrocytes and cardiomyocytes may not be evolutionarily conserved, the high degree of gene conservation supports the use of this model for the identification of genetic pathways underlying human heart function. We used both proteomics and genetics to identify SPARC as an important component of cardiac function in *Drosophila*, highlighting the possibility that SPARC's role in the heart may be evolutionarily conserved from flies to humans. By using a cell-specific and temporally conditional nephrocyte loss of function paradigm, we establish that pericardial nephrocytes sustain normal heart function in adult *Drosophila*. Importantly, it was shown that nephrocytes prevent the development of a SPARC-dependent cardiomyopathy, a finding of considerable importance because SPARC is emerging as a clinically important target for the control of tissue fibrosis in humans.^[@R33],[@R34]^ Collectively, these findings highlight the importance of the *Drosophila* heart model as a means of identifying and studying cardiomodulatory signals of relevance to human cardiac function and suggest that changes to SPARC in humans may contribute to cardiac dysfunction in disease and aging.

Our data reaffirm that pericardial nephrocytes mediate noncell autonomous mechanisms controlling *Drosophila* heart function. The findings also suggest that the changes in heart morphology and the increased arrhythmias seen in *dKlf15*^*NN*^ mutants were not only because of interactions between the cardiomyocytes and nephrocytes during preadult stages but also that adult heart rate is mediated by an on-going interaction between the cardiomyocytes and nephrocytes. Thus, it can be concluded that loss of nephrocytes or nephrocyte function both developmentally or acutely in adults, leads to cardiac dysfunction. Our data also suggest that the cardiomyopathy caused by loss of nephrocytes or nephrocyte function is linked to the nephrocytes' role in peripheral clearance.

To our knowledge, our data set represents the first examination of the adult *Drosophila* hemolymph proteome. The most abundant protein in the hemolymph of both wild-type and *dKlf15*^*NN*^ mutants was Rfabg. Rfabg is a lipid transporter found in insect hemolymph and known to be required for Hedgehog and Wingless signaling.^[@R35]^ There were also large signals for several important intracellular metabolic proteins (eg, aldolase, enolase, and subunits of the glyceraldehyde phosphate dehydrogenase enzyme). The presence of intracellular proteins is a feature of the human plasma proteome, suggesting that intracellular proteins are a constituent of circulating fluids in animals. We also recorded an expected absence or near-absence from the adult hemolymph of the larval serum proteins LSP1α, LSP1β, LSP1γ, and LSP2, all of which are among the most highly represented proteins in larval hemolymph.^[@R30]^ The LSPs are metabolized during the nonfeeding third instar and pupal stages, hence our data indicate that by the first week of adulthood, they are difficult to detect in the hemolymph.

In addition, there were proteins identified in both genotypes, which were significantly upregulated or downregulated in the hemolymph of *dKlf15*^*NN*^ mutants (group 2). The most highly upregulated signals were ascribed to genes with unknown functions (CG18067, CG15293, and CG14961) and proteins involved in immunity and clotting (gelsolin, immune-induced peptides 10 and 23, and the Defence protein l(2)34F). Although not reaching statistical significance, necrotic, an immune modulatory serpin removed from circulation by nephrocytes,^[@R1]^ trended toward accumulating in the mutants' hemolymph of the mutants. In addition, there was a significant reduction in the mutants' hemolymph of peroxiredoxin 5, an antioxidant that also negatively regulates the immune response.^[@R36]^ Collectively, these findings suggest that the mutant flies may have modified immune responses, and this is currently under investigation.

The most abundant proteins identified only in the hemolymph of the *dKlf15*^*NN*^ mutants were DE-cadherin and SPARC. DE-cadherin mediates cell adhesion and is critical for embryonic development and is present in the medulla of the lymph gland,^[@R37]^ whereas SPARC stabilizes basal lamina by interacting with collagen IV, an interaction critical for normal development.^[@R38],[@R39]^ In contrast, the role of SPARC in postembryonic and adult *Drosophila* remains unclear. Mammalian SPARC directly binds to collagen as well as growth factors^[@R40]^ and is associated with a diverse range of pathologies, including the maintenance of cardiac integrity^[@R41]^ and metabolic syndrome.^[@R42]^ Our data indicate that a SPARC-dependent cardiomyopathy is prevented in the *Drosophila* model via a nephrocyte-mediated clearance mechanism. Peripheral clearance of macromolecules is fundamentally important to tissue homeostasis but difficult to study in mammals. Although few studies exist, it is interesting to note that disruption of peripheral clearance by liver sinusoidal cells in stabilin-1 and stabilin-2 knockout mice led to local and systemic tissue fibrosis, albeit without an increase in circulating SPARC levels being detected.^[@R43]^ It remains to be verified whether the increased SPARC levels directly cause cardiomyopathy or whether it is because of other hemolymph factors that are increased in *dKlf15*^*NN*^ mutants that act via a SPARC-dependent pathway.

Although abnormal cardiomyocyte function in *dKlf15*^*NN*^ mutants could be rescued by reducing *SPARC* gene dosage, we could not confirm whether this was an effect of reduced *SPARC* expression in the cardiomyocytes, because *SPARC* knockdown in wild-type cardiomyocytes led to a severe cardiomyopathy, characterized by reduced fractional shortening (Figure II in the Data Supplement). Hence, rescue of the cardiomyopathy by reducing *SPARC* gene dosage in the nephrocyte-free *dKlf15*^*NN*^ mutants may have been because of either a less severe reduction in *SPARC* expression in the cardiomyocytes or reduced *SPARC* expression in cells other than cardiomyocytes. Interestingly, moderate reductions in *ILK* expression in whole flies can extend lifespan and retard cardiac ageing, yet strong knockdown in cardiomyocytes has a profound negative impact on cardiac function.^[@R8]^ Thus, different phenotypes can develop in the heart as a consequence of differing levels of gene silencing/gene dosage.

In summary, the *Drosophila* heart can develop a *SPARC*-dependent cardiomyopathy as a result of nephrocyte loss. These findings identify *Drosophila* as a highly tractable model system with which to study the important relationship between tissue homeostasis and peripheral clearance, especially as it relates to human cardiac physiology. The next step will, therefore, be to establish how SPARC contributes to cardiac function in *Drosophila* and explore whether these mechanisms are conserved and relevant to the human heart.
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CLINICAL PERSPECTIVE {#s1}
====================

In this work, we identified a genetic pathway in *Drosophila* linking cardiac function with the matricellular protein secreted protein acidic and rich in cysteine (SPARC). Changes to *SPARC* gene expression or protein levels in humans are associated with cardiac aging, chronic inflammatory disease, and metabolic syndrome. SPARC controls collagen deposition as well as mitogenic signaling and, as such, it is a potential clinical target with which to control scarring and organ dysfunction. It has been noted that *Drosophila* heart function is regulated by pericardial nephrocytes, highly endocytic kidney-like cells that flank the heart and filter the fly's blood. Our research aims to understand this relationship because the mechanisms involved may be relevant to the regulation of the human heart. To address this, we genetically ablated the nephrocytes and analyzed heart function as well as the blood proteome, in the hope of discovering cardiomodulatory peptides. We found that nephrocyte loss led to a severe cardiomyopathy, characterized by tissue remodeling and a slow, irregular heartbeat. Proteomics revealed an accumulation of many circulating proteins, most notably SPARC. We then conducted genetic loss of function experiments and established that the cardiomyopathy was dependent on *SPARC*. It remains to be seen whether this link involves SPARC's role in collagen deposition or a novel, uncharacterized mechanism. Nevertheless, by establishing a link between *SPARC* and cardiac function in *Drosophila* we now have a new, powerful tool in the research armoury with which to ascertain how *SPARC* contributes to cardiac function in humans.
